World Investment Advisors LLC Decreases Stake in Mettler-Toledo International Inc. (NYSE:MTD)

World Investment Advisors LLC decreased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 0.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,844 shares of the medical instruments supplier’s stock after selling 9 shares during the quarter. World Investment Advisors LLC’s holdings in Mettler-Toledo International were worth $4,265,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC increased its stake in Mettler-Toledo International by 1.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 1,158 shares of the medical instruments supplier’s stock valued at $1,619,000 after purchasing an additional 14 shares in the last quarter. OFI Invest Asset Management acquired a new position in shares of Mettler-Toledo International during the 2nd quarter worth $802,000. Parsons Capital Management Inc. RI boosted its position in shares of Mettler-Toledo International by 7.2% in the 2nd quarter. Parsons Capital Management Inc. RI now owns 2,681 shares of the medical instruments supplier’s stock worth $3,747,000 after buying an additional 180 shares in the last quarter. Carnegie Investment Counsel grew its stake in Mettler-Toledo International by 0.8% in the 2nd quarter. Carnegie Investment Counsel now owns 13,963 shares of the medical instruments supplier’s stock valued at $19,514,000 after acquiring an additional 109 shares during the last quarter. Finally, Walter Public Investments Inc. increased its holdings in Mettler-Toledo International by 26.6% during the 2nd quarter. Walter Public Investments Inc. now owns 10,453 shares of the medical instruments supplier’s stock valued at $14,609,000 after acquiring an additional 2,194 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Trading Up 0.5 %

Shares of NYSE:MTD opened at $1,276.92 on Friday. The firm has a market cap of $26.94 billion, a price-to-earnings ratio of 34.43, a PEG ratio of 4.19 and a beta of 1.13. The stock’s 50-day moving average price is $1,309.36 and its two-hundred day moving average price is $1,378.81. Mettler-Toledo International Inc. has a 12-month low of $1,115.44 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. As a group, research analysts forecast that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Analysts Set New Price Targets

MTD has been the topic of several recent research reports. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Wells Fargo & Company lowered their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Robert W. Baird cut their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Stifel Nicolaus reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Finally, Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.